当前位置:
X-MOL 学术
›
J. Child Adolesc. Psychopharmacol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Long-Term Improvement and Safety of Aripiprazole for Irritability and Adaptive Function in Asian Children and Adolescents with Autistic Disorder: A 52-Week, Multinational, Multicenter, Open-Label Study
Journal of Child and Adolescent Psychopharmacology ( IF 1.9 ) Pub Date : 2022-09-15 , DOI: 10.1089/cap.2022.0004 Byoung-Uk Kim 1 , Hyo-Won Kim 2 , Eun Jin Park 3 , Ji-Hoon Kim 4 , Vitharon Boon-Yasidhi 5 , Jariya Tarugsa 5 , Alexis Reyes 6 , Stella G Manalo 7, 8 , Yoo-Sook Joung 9
Journal of Child and Adolescent Psychopharmacology ( IF 1.9 ) Pub Date : 2022-09-15 , DOI: 10.1089/cap.2022.0004 Byoung-Uk Kim 1 , Hyo-Won Kim 2 , Eun Jin Park 3 , Ji-Hoon Kim 4 , Vitharon Boon-Yasidhi 5 , Jariya Tarugsa 5 , Alexis Reyes 6 , Stella G Manalo 7, 8 , Yoo-Sook Joung 9
Affiliation
Objective: Evaluate the long-term improvement and safety of aripiprazole in treating irritability in Asian children and adolescents (6–17 years) with autistic disorder.
中文翻译:
阿立哌唑对亚洲儿童和自闭症青少年易怒和适应功能的长期改善和安全性:一项为期 52 周、多国、多中心、开放标签的研究
目的:评估阿立哌唑治疗亚洲儿童和青少年(6-17 岁)自闭症易激惹的长期改善和安全性。
更新日期:2022-09-16
中文翻译:
阿立哌唑对亚洲儿童和自闭症青少年易怒和适应功能的长期改善和安全性:一项为期 52 周、多国、多中心、开放标签的研究
目的:评估阿立哌唑治疗亚洲儿童和青少年(6-17 岁)自闭症易激惹的长期改善和安全性。